We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    The Worldwide Sarcoidosis Research Study
Previous Study | Return to List | Next Study

Worldwide Sarcoidosis Research Study (WISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01610843
Recruitment Status : Recruiting
First Posted : June 4, 2012
Last Update Posted : March 30, 2017
Information provided by (Responsible Party):

May 31, 2012
June 4, 2012
March 30, 2017
December 2011
December 2020   (Final data collection date for primary outcome measure)
Define and characterize sarcoidosis phenotypes and methods of care [ Time Frame: Anticipated by 2017 ]
To give a broader and less biased view of sarcoidosis
Not Provided
Complete list of historical versions of study NCT01610843 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Worldwide Sarcoidosis Research Study
Worldwide Sarcoidosis Research Study

The aim of this study is to collect information about the clinical course and characteristics of sarcoidosis patients around the world through web-based surveys. Recruitment is directed at and driven by patients in the sarcoidosis community. This will allow the the investigators to study sarcoidosis patients across all demographic, geographic, and socioeconomic boundaries, not just patients seen at large research centers. The investigators believe this study can give investigators a broader and less biased view of sarcoidosis. The investigators would also like to collect genetic samples on this population to assess genetic variance in different phenotypes.

The information for the study would be provided through a web based survey system that can be accessed by patients or physicians of patients from any computer with Internet access. This system would collect clinical information in sufficient detail so that the phenotype of individual patients can be evaluated. Upon agreeing to participate in further research studies through the website, subjects will also have the opportunity to provide a DNA sample.

Not Provided
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Saliva samples will be collected and processed at the University of Iowa.
Non-Probability Sample
Individuals diagnosed with sarcoidosis who have a computer with Internet access.
Other: Survey
Longitudinal surveys
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 2020
December 2020   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of Sarcoidosis
  • Access to a computer with Internet

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact: Alicia K Gerke, MD 319-356-1869 alicia-gerke@uiowa.edu
Contact: Emily K Phillips, BSN 319-356-1869 emily-phillips@uiowa.edu
United States
5UL1RR024979 ( U.S. NIH Grant/Contract )
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Alicia Gerke, University of Iowa
University of Iowa
National Center for Research Resources (NCRR)
Principal Investigator: Alicia K Gerke, MD University of Iowa
University of Iowa
March 2017